Tag:
Parexel
Latest Headlines
Latest Headlines
Icon goes on hiring spree as analysts chide CROs on deal risks
Shares of Icon and Parexel slipped a bit yesterday as a crowd of analysts gathered around to criticize the CROs on the downside of a new wave of strategic relationships with Big Pharma companies.
Parexel laying off 300, closing early-phase CRO facilities
The big CRO Parexel outlined plans to restructure its early-stage research efforts last month, offering a big-picture effort to cut back by 30 percent. Now the axe is falling on all nine of its
Pfizer turns to CROs as it upends huge R&D operation
As Pfizer hatchets billions of dollars from its R&D budget it's turning to two CROs as preferred providers for outsourcing its clinical trial work. In separate releases Parexel and Icon both
Parexel to restructure early-phase R&D as shares plunge
Shares of Parexel International took a beating this morning after the CRO noted a shortfall in early-phase research work that is triggering a restructuring in that segment of its drug research
Merck teams with Parexel for biosimilars
Merck is boosting its biologics unit in a deal with Parexel. The CRO will provide its clinical development services for Merck BioVenture, including access to regulatory strategy and clinical
PAREXEL develops cold-chain data system
Global contract researcher PAREXEL has stepped into the cold chain business. The company has unveiled an integrated study-drug transport system for temperature monitoring based on radio-frequency
Quintiles backs away from possible ClinPhone bid
After flirting with the idea of making a competing offer for ClinPhone , Quintiles Transnational has backed away from the table,
Parexel, Quintiles may battle for ClinPhone
CRO Parexel has made a $182 million bid for U.K.-based ClinPhone, but it may be facing competition from Quintiles, the world's largest private CRO. ClinPhone helps drug developers select trial
